Viewing Study NCT06326034


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2025-12-26 @ 4:42 PM
Study NCT ID: NCT06326034
Status: COMPLETED
Last Update Posted: 2024-03-22
First Post: 2024-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients
Sponsor: Mohammed Mahmood Mohammed
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-05-01
Start Date Type: ACTUAL
Primary Completion Date: 2023-01-01
Primary Completion Date Type: ACTUAL
Completion Date: 2023-01-01
Completion Date Type: ACTUAL
First Submit Date: 2024-03-16
First Submit QC Date: None
Study First Post Date: 2024-03-22
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-16
Last Update Post Date: 2024-03-22
Last Update Post Date Type: ACTUAL